Anika Therapeutics, Inc. (ANIK)
21.57
+0.46
(+2.18%)
USD |
NASDAQ |
Sep 02, 16:00
21.57
0.00 (0.00%)
After-Hours: 16:56
Anika Therapeutics Net Income (TTM) : -3.121M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.121M |
| March 31, 2026 | -11.08M |
| December 31, 2025 | -9.979M |
| September 30, 2025 | -14.27M |
| June 30, 2025 | -12.94M |
| March 31, 2025 | -10.83M |
| December 31, 2024 | -8.828M |
| September 30, 2024 | -8.712M |
| June 30, 2024 | -13.44M |
| March 31, 2024 | -13.64M |
| December 31, 2023 | -22.04M |
| September 30, 2023 | -24.58M |
| June 30, 2023 | -22.17M |
| March 31, 2023 | -22.28M |
| December 31, 2022 | -14.86M |
| September 30, 2022 | -15.74M |
| June 30, 2022 | -11.01M |
| March 31, 2022 | -1.637M |
| December 31, 2021 | 4.134M |
| September 30, 2021 | -5.73M |
| June 30, 2021 | -12.70M |
| March 31, 2021 | -26.94M |
| December 31, 2020 | -23.98M |
| September 30, 2020 | -4.275M |
| June 30, 2020 | 11.34M |
| Date | Value |
|---|---|
| March 31, 2020 | 28.48M |
| December 31, 2019 | 27.19M |
| September 30, 2019 | 30.86M |
| June 30, 2019 | 29.26M |
| March 31, 2019 | 29.92M |
| December 31, 2018 | 18.72M |
| September 30, 2018 | 19.07M |
| June 30, 2018 | 18.36M |
| March 31, 2018 | 19.64M |
| December 31, 2017 | 31.82M |
| September 30, 2017 | 31.83M |
| June 30, 2017 | 33.90M |
| March 31, 2017 | 31.14M |
| December 31, 2016 | 32.55M |
| September 30, 2016 | 35.50M |
| June 30, 2016 | 34.93M |
| March 31, 2016 | 34.14M |
| December 31, 2015 | 30.76M |
| September 30, 2015 | 27.53M |
| June 30, 2015 | 25.32M |
| March 31, 2015 | 26.80M |
| December 31, 2014 | 38.32M |
| September 30, 2014 | 37.16M |
| June 30, 2014 | 35.94M |
| March 31, 2014 | 32.54M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Perspective Therapeutics, Inc. | -116.63M |
| MiMedx Group, Inc. | 6.239M |
| ABVC BioPharma, Inc. | -7.600M |
| Enovis Corp. | -1.099B |
| Edwards Lifesciences Corp. | 978.60M |